ELA 2015

ELA 2015 - Advances in LabAutomation & Robotics

 

SELECTBIO, the organisers of this track of the ELA 2015 conference programme are presenting a collection of speakers with experience in laboratory automation.  The three sessions are broadly divided into hardware, software and science.  In the hardware section, industrial suppliers from the areas of robotics, components and lab-on-a-chip will cover current and future trends in equipment supply for the lab automation business. For software we have thought leaders from control software, LIMS and the SiLA standards organisation.  Finally the science section will allow innovative thinkers from industry and academia to present new ideas.

 

Anthony Davies

Director of Translational Cell Imaging, The Queensland University of Technology

Malcolm Crook

Director, Peak Analysis & Automation PAA Ltd

Ross King

Professor of Machine Intelligence,University of Manchester

 

Download PDFs:

ELA2015-Rooms

ELA2015-Hall-Position

 

ELA 2015

Automation Leaders Siemens and Inpeco Extend Long-Term Partnership

Siemens Healthcare Diagnostics and Inpeco have signed a new contract that extends the companies’ long-lasting status as preferred partners in laboratory automation. Siemens and Inpeco will be working closely together to design and deliver complex, custom solutions to help our customers meet their business and clinical needs.

Siemens and Inpeco have been jointly pioneering in the field of laboratory automation since 1999. Siemens is the market leader in laboratory automation installations, with the largest installed base of total laboratory automation solutions in the world. Inpeco, a highly-respected innovator of laboratory automation products, has played a key role in that success. Siemens has successfully installed more than a thousand track-based total lab automation solutions, and the Siemens-Inpeco partnership is responsible for the majority of these, including the longest and most complex automation tracks ever built. The Siemens-Inpeco partnership combines the market-leading strengths of each company. “Siemens’ expertise in engineering, project management and workflow design together with Inpeco’s innovation power is a proven, winning combination,” said Franz Walt, CEO, Chemistry, Immunoassay, Automation and Diagnostics IT Business Unit, Diagnostics Division, Siemens Healthcare. “That’s why the world’s largest laboratories trust us to improve turnaround times, cut costs and reduce errors for improved patient outcomes.” “The strengths that we each bring to this partnership allow Siemens and Inpeco to consciously address the growing demand for advanced and innovative TLA solutions,” said Andrea Pedrazzini, President, Inpeco. “Laboratory medicine and healthcare require reliable and self-sufficient solutions capable of delivering seamless performance and full satisfaction to our customers and we work hard every day to reach these goals.” Together, Siemens and Inpeco share a proud 15-year tradition of excellence in laboratory automation.

As a result of this long term contract, the Siemens-Inpeco partnership will continue to transform diagnostic medicine with Lean total laboratory automation solutions that are scalable, flexible, reliable, multi-disciplinary, and enable connectivity to third party analyzers.

 

See more at: SelectScience

Automation Leaders Siemens and Inpeco Extend Long-Term Partnership

Benchmark technological developments and explore best practices in biomanufacturing

The Bio Pharmaceutical industry is making a capital investment of approximately $8 billion in new facilities in Ireland, most of which has come in the last 10 years, representing close to the biggest wave of investment in new BioTech facilities anywhere in the world.

Join us at BioProduction 2015 in Dublin this October to see why so much is being invested in this area and to network with leading players within this growing industry!

 

BioProduction 2015: Europe’s leading and largest event for a comprehensive update on all aspects of large scale biological manufacturing. Providing insights on the latest technologies, upstream/downstream processing, process analytics, the implementation of continuous manufacturing, facility design, flexibility facilities and single use systems to reduce inefficiencies during the bio manufacturing process.

4 Conferences – 1 Exhibition - 1 Congress

• Conference 1: Continuous Manufacturing


• Conference 2: Upstream Processing- Production, Development & Analytics


• Conference 3: Manufacturing Strategy & Technology


• Conference 4: Downstream Processing

 

250+ Industry Experts – 130+ Companies Represented – 10 Interactive Discussions

 

Global panel of senior level industry professionals companies including:

• 
  Sean McEwen, Vice President, Biologics Manufacturing, AbbVie Manufacturing Mgmt Ltd, Ireland


• 
  Guy McDonnell, Director of Engineering &EHS, Pfizer, Ireland


• 
  Trent Carrier, Vice President, Vaccine Technology & Engineering, Takeda Vaccines, USA


• 
  Roman Necina, Vice President Process Science & Technical Operations, Baxalta, Austria


• 
  Thilo Henckel, Vice President Manufacturing, Roche Diagnostics GmbH, Germany


• 
  Lada Laenen, Senior Director; Allston Landing Manufacturing Science and Technologies Head, Genzyme Corporation, USA


• 
  Lars Dreesmann, Executive Director, Head of Clinical Supply & Transfer, Biopharma Bioprocess & Pharmaceutical Development, Boehringer Ingelheim, Germany


• 
  Ciaran Brady, Director, Biotech Technical Services/ Manufacturing Sciences, Eli Lilly and Company, Ireland


• 
  Joe Runner, Manufacturing Technical Specialist, Genentech, USA


• 
  Weibing Ding, Principal Scientist, Process Development, Amgen Inc., USA

 

For more information on the 2015 event please visit the event website at www.bio-production.com

Benchmark technological developments and explore best practices in biomanufacturing

BioData World Congress 2015

Are you, like Barack Obama, trying to push the science of genomics to the next leveI - the development of precision medicines?

You will be in good company if you are. Leading healthcare institutes across the world are grappling with this thorny challenge and many have found some very innovative and exciting solutions. These initiatives will be showcased, discussed and debated at one of the most exciting and innovative events in the genomics calendar.

The BioData World Congress, held at the Wellcome Genome Campus this October will:

• Use novel formats to address the challenges in getting the benefits of genomic science to the patient - including narrative drama, roundtables, site visits and TED style talks


• examine the science and technology that is shaping and revolutionising our understanding of disease


• review the game changing innovation, roadblocks and critical success factors in the utilisation of genomic data


• identify how big data is driving developments in precision medicine

Ticket prices start at £350. Register now to receive the best possible rates

We have an amazing faculty, a veritable who’s who in genomics, headlined by Eric Green from NHGRI and supported by visionaries from across the globe including The Broad Institute, Google, Harvard Medical School, EMBL-EBI, Wellcome Trust Sanger Institute, and Genomics England.

Quote discount code XSJJ

For more information please visit event website

To download the brochure please click HERE

BioData World Congress 2015

What is better than a Hamilton STARlet?

Exactly, a Star Plus. Basically it is the same maschine, just 2 of those connected to each other.

As you can only mount one arm to a single Hamilton Star(let), this setup opens a whole new level of

possibilities. You can, for instance, have the first Starlet equiped with a multichannel arm which

prepares your samples on a MTP and than hand over the plate to the second maschine equiped with a

96-Head to perform the whole workup of your assay. Great, isn`t it!

So this is the benefit for the user, but why does Hamilton not just construct a larger maschine?

This a question has a few anserws:

- Hamilton dont have to invent new parts, but only a connector between the 2 Starlets

- There might be a stability problem for the whole maschine if you (just) enlarge parts

- Shipment and build up is more comfortable with smaller parts

- The user can seperate both Starlets if he/she decides to continue with different assays

 

Here you can see a pdf of a Hamilton STAR plus setup:

A_fully_automated_system_for_storage_of_compounds_and_assay_plate_production_from_compound_stocks

What is better than a Hamilton STARlet?